ARZTY vs UMEWF
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARZTY is a Hold and UMEWF is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ARZTY’s FA Score shows that 1 FA rating(s) are green whileUMEWF’s FA Score has 0 green FA rating(s).
- ARZTY’s FA Score: 1 green, 4 red.
- UMEWF’s FA Score: 0 green, 5 red.
Price Growth
ARZTY (@Food: Specialty/Candy) experienced а -7.48% price change this week, while UMEWF (@Food: Specialty/Candy) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Food: Specialty/Candy industry was +0.38%. For the same industry, the average monthly price growth was +0.65%, and the average quarterly price growth was +13.53%.
Industries' Descriptions
@Food: Specialty/Candy (+0.38% weekly)A specialty/candy manufacturer specializes in one or more of the following: chocolate, candies, pasta, condiments, seasonings, among other items. Hershey Company, McCormick & Company and J.M. Smucker Company are some of the major firms in this segment. Demand for this industry’s products comes from both institutions/restaurants as well as households.
| ARZTY | UMEWF | ARZTY / UMEWF | |
| Capitalization | 1.7B | 47.1M | 3,605% |
| EBITDA | 244M | -148.96K | -163,798% |
| Gain YTD | 15.452 | -7.500 | -206% |
| P/E Ratio | 33.22 | N/A | - |
| Revenue | 1.96B | 4 | 48,950,000,000% |
| Total Cash | 186M | 8.47K | 2,197,023% |
| Total Debt | 428M | 2.36M | 18,159% |
ARZTY | UMEWF | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 82 Overvalued | 98 Overvalued | |
PROFIT vs RISK RATING 1..100 | 28 | 71 | |
SMR RATING 1..100 | 88 | 96 | |
PRICE GROWTH RATING 1..100 | 41 | 64 | |
P/E GROWTH RATING 1..100 | 36 | 100 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ARZTY's Valuation (82) in the null industry is in the same range as UMEWF (98). This means that ARZTY’s stock grew similarly to UMEWF’s over the last 12 months.
ARZTY's Profit vs Risk Rating (28) in the null industry is somewhat better than the same rating for UMEWF (71). This means that ARZTY’s stock grew somewhat faster than UMEWF’s over the last 12 months.
ARZTY's SMR Rating (88) in the null industry is in the same range as UMEWF (96). This means that ARZTY’s stock grew similarly to UMEWF’s over the last 12 months.
ARZTY's Price Growth Rating (41) in the null industry is in the same range as UMEWF (64). This means that ARZTY’s stock grew similarly to UMEWF’s over the last 12 months.
ARZTY's P/E Growth Rating (36) in the null industry is somewhat better than the same rating for UMEWF (100). This means that ARZTY’s stock grew somewhat faster than UMEWF’s over the last 12 months.
| RSI ODDS (%) |
| Stochastic ODDS (%) |
| Momentum ODDS (%) |
| MACD ODDS (%) |
| TrendWeek ODDS (%) |
| TrendMonth ODDS (%) |
| Advances ODDS (%) |
| Declines ODDS (%) |
| BollingerBands ODDS (%) |
| Aroon ODDS (%) |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PBE | 68.11 | -0.25 | -0.36% |
| Invesco Biotechnology & Genome ETF | |||
| DLS | 65.78 | -0.38 | -0.57% |
| WisdomTree International SmallCp Div ETF | |||
| SURI | 17.50 | -0.23 | -1.27% |
| Simplify Propel Opportunities ETF | |||
| OCTZ | 39.87 | -0.65 | -1.60% |
| TrueShares Structured Outcome OctoberETF | |||
| IGV | 100.45 | -3.55 | -3.41% |
| iShares Expanded Tech-Software Sect ETF | |||
ARZTY and
Correlation & Price change
A.I.dvisor tells us that ARZTY and PRRFY have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARZTY and PRRFY's prices will move in lockstep.
| Ticker / NAME | Correlation To ARZTY | 1D Price Change % | ||
|---|---|---|---|---|
| ARZTY | 100% | N/A | ||
| PRRFY - ARZTY | 23% Poorly correlated | N/A | ||
| UMEWF - ARZTY | 22% Poorly correlated | N/A | ||
| ARRT - ARZTY | 8% Poorly correlated | N/A | ||
| AMNF - ARZTY | 2% Poorly correlated | -0.65% | ||
| ASBFF - ARZTY | 1% Poorly correlated | N/A | ||
More | ||||
UMEWF and
Correlation & Price change
A.I.dvisor tells us that UMEWF and SOWG have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that UMEWF and SOWG's prices will move in lockstep.
| Ticker / NAME | Correlation To UMEWF | 1D Price Change % | ||
|---|---|---|---|---|
| UMEWF | 100% | N/A | ||
| SOWG - UMEWF | 22% Poorly correlated | +9.69% | ||
| ARZTY - UMEWF | 22% Poorly correlated | N/A | ||
| TATYY - UMEWF | 8% Poorly correlated | N/A | ||
| TOFB - UMEWF | 6% Poorly correlated | N/A | ||
| TBLMF - UMEWF | 4% Poorly correlated | N/A | ||
More | ||||